001     140841
005     20230915100838.0
024 7 _ |a 10.1007/s00103-019-02985-z
|2 doi
024 7 _ |a pmid:31297549
|2 pmid
024 7 _ |a 1436-9990
|2 ISSN
024 7 _ |a 1437-1588
|2 ISSN
024 7 _ |a altmetric:66840263
|2 altmetric
037 _ _ |a DZNE-2020-07163
041 _ _ |a ger
082 _ _ |a 610
100 1 _ |a Michalowsky, Bernhard
|0 P:(DE-2719)2810763
|b 0
|e First author
245 _ _ |a [The economic and social burden of dementia diseases in Germany-A meta-analysis].
260 _ _ |a Heidelberg
|c 2019
|b Springer
264 _ 1 |3 online
|2 Crossref
|b Springer Science and Business Media LLC
|c 2019-07-11
264 _ 1 |3 print
|2 Crossref
|b Springer Science and Business Media LLC
|c 2019-08-01
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1688391552_14566
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Currently, there are 1.7 million people living with dementia (PwD) in Germany. This number is expected to double within the next decades. Estimates of the total societal economic burden of dementia are currently missing.The aim was to estimate the current and future total cost and excess cost of dementia from a public payer and societal perspective.Studies demonstrating the healthcare resource utilization of PwD in Germany were identified. Utilization data were aggregated using the sample size of different studies as a weight. Annual per capita costs of PwD and excess cost of dementia were calculated using standardized unit costs. Current and future costs were calculated based on published prevalence and population forecasts.PwD living at home had lower costs from a payer perspective compared to those who are institutionalized, but higher total societal cost due to the higher informal care time. The total cost for PwD from a payer perspective was 34 billion € in 2016. These costs could reach 90 billion € by 2060. The excess cost of dementia was 18 billion € in 2016 and is estimated to become 49 billion € by 2060 from a payer perspective, representing 54% of the total cost of PwD and up to 15% of the total costs associated with the elderly population. The total societal cost was 73 billion € in 2016 and is estimated to become 194 billion € by 2060. The excess cost of dementia was 54 billion € in 2016 and is estimated to become 145 billion € by 2060, representing 74% of the total societal cost of PwD and 36% of the total societal cost of the elderly.Dementia diseases represent a tremendous social and economic burden. Without a cure, supporting caregivers and implementing interventions that delay the functional and cognitive decline will be crucial to relieving the increasing costs.
536 _ _ |a 344 - Clinical and Health Care Research (POF3-344)
|0 G:(DE-HGF)POF3-344
|c POF3-344
|f POF III
|x 0
542 _ _ |i 2019-07-11
|2 Crossref
|u https://creativecommons.org/licenses/by/4.0
588 _ _ |a Dataset connected to CrossRef, PubMed,
650 _ 2 |a Aged
|2 MeSH
650 _ 2 |a Aged, 80 and over
|2 MeSH
650 _ 2 |a Aging
|2 MeSH
650 _ 2 |a Caregivers: economics
|2 MeSH
650 _ 2 |a Caregivers: statistics & numerical data
|2 MeSH
650 _ 2 |a Cost of Illness
|2 MeSH
650 _ 2 |a Dementia: economics
|2 MeSH
650 _ 2 |a Dementia: psychology
|2 MeSH
650 _ 2 |a Germany
|2 MeSH
650 _ 2 |a Health Care Costs: statistics & numerical data
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Patient Acceptance of Health Care
|2 MeSH
650 _ 2 |a Resource Allocation
|2 MeSH
700 1 _ |a Rädke, Anika
|0 P:(DE-2719)9001134
|b 1
|u dzne
700 1 _ |a Hoffmann, Wolfgang
|0 P:(DE-2719)2000040
|b 2
|e Last author
773 1 8 |a 10.1007/s00103-019-02985-z
|b : Springer Science and Business Media LLC, 2019-07-11
|n 8
|p 981-992
|3 journal-article
|2 Crossref
|t Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
|v 62
|y 2019
|x 1436-9990
773 _ _ |a 10.1007/s00103-019-02985-z
|g Vol. 62, no. 8, p. 981 - 992
|0 PERI:(DE-600)1470303-8
|n 8
|q 62:8<981 - 992
|p 981-992
|t Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz
|v 62
|y 2019
|x 1436-9990
856 4 _ |u https://pub.dzne.de/record/140841/files/DZNE-2020-07163.pdf
|y OpenAccess
856 4 _ |u https://pub.dzne.de/record/140841/files/DZNE-2020-07163.pdf?subformat=pdfa
|x pdfa
|y OpenAccess
909 C O |o oai:pub.dzne.de:140841
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 0
|6 P:(DE-2719)2810763
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 1
|6 P:(DE-2719)9001134
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 2
|6 P:(DE-2719)2000040
913 1 _ |a DE-HGF
|b Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-344
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
914 1 _ |y 2019
915 _ _ |a Creative Commons Attribution CC BY 4.0
|0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2022-11-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2022-11-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2022-11-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2022-11-16
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b BUNDESGESUNDHEITSBLA : 2021
|d 2022-11-16
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2022-11-16
920 1 _ |0 I:(DE-2719)5000001
|k AG Grabe
|l Biomarkers of Dementia in the General Population
|x 0
920 1 _ |0 I:(DE-2719)1510600
|k AG Hoffmann
|l Translational Health Care Research
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)5000001
980 _ _ |a I:(DE-2719)1510600
980 _ _ |a UNRESTRICTED
980 1 _ |a FullTexts
999 C 5 |y 2016
|2 Crossref
|t Die Häufigkeit von Demenzerkrankungen
|o Deutsche Alzheimer Gesellschaft e. V. Die Häufigkeit von Demenzerkrankungen 2016
999 C 5 |y 2015
|2 Crossref
|t Die Epidemiologie der Demenz. Das Wichtigste
|o Deutsche Alzheimer Gesellschaft e. V. Die Epidemiologie der Demenz. Das Wichtigste 2015
999 C 5 |9 -- missing cx lookup --
|a 10.3233/JAD-150935
|2 Crossref
|o 10.3233/JAD-150935
999 C 5 |y 2011
|2 Crossref
|o JR Thyrian 2011
999 C 5 |9 -- missing cx lookup --
|a 10.1007/s10198-017-0869-7
|2 Crossref
|o 10.1007/s10198-017-0869-7
999 C 5 |9 -- missing cx lookup --
|a 10.1111/inr.12194
|2 Crossref
|o 10.1111/inr.12194
999 C 5 |y 2016
|2 Crossref
|t Gesundheits, Krankheitskosten 2002, 2004, 2006, 2008 und 2015
|o Statistisches Bundesamt Gesundheits, Krankheitskosten 2002, 2004, 2006, 2008 und 2015 2016
999 C 5 |9 -- missing cx lookup --
|a 10.3233/JAD-140354
|2 Crossref
|o 10.3233/JAD-140354
999 C 5 |9 -- missing cx lookup --
|a 10.2147/JMDH.S80560
|2 Crossref
|o 10.2147/JMDH.S80560
999 C 5 |9 -- missing cx lookup --
|a 10.3233/JAD-2011-110539
|2 Crossref
|o 10.3233/JAD-2011-110539
999 C 5 |9 -- missing cx lookup --
|a 10.1186/1471-2318-10-24
|2 Crossref
|o 10.1186/1471-2318-10-24
999 C 5 |9 -- missing cx lookup --
|a 10.1007/s12603-010-0311-7
|2 Crossref
|o 10.1007/s12603-010-0311-7
999 C 5 |9 -- missing cx lookup --
|a 10.1111/j.1600-0447.2011.01741.x
|2 Crossref
|o 10.1111/j.1600-0447.2011.01741.x
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.jamda.2017.10.013
|2 Crossref
|o 10.1016/j.jamda.2017.10.013
999 C 5 |9 -- missing cx lookup --
|a 10.3233/JAD-122392
|2 Crossref
|o 10.3233/JAD-122392
999 C 5 |9 -- missing cx lookup --
|a 10.3233/JAD-180275
|2 Crossref
|o 10.3233/JAD-180275
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.jamda.2013.10.003
|2 Crossref
|o 10.1016/j.jamda.2013.10.003
999 C 5 |9 -- missing cx lookup --
|a 10.1016/0022-3956(75)90026-6
|2 Crossref
|o 10.1016/0022-3956(75)90026-6
999 C 5 |9 -- missing cx lookup --
|a 10.1186/2046-4053-4-1
|2 Crossref
|o 10.1186/2046-4053-4-1
999 C 5 |y 2015
|2 Crossref
|o JO Bock 2015
999 C 5 |y 2015
|2 Crossref
|t Verdienste und Arbeitskosten – Arbeitnehmerverdienste
|o Statistisches Bundesamt Verdienste und Arbeitskosten – Arbeitnehmerverdienste 2015
999 C 5 |9 -- missing cx lookup --
|a 10.1007/s40273-016-0468-y
|2 Crossref
|o 10.1007/s40273-016-0468-y
999 C 5 |y 2013
|2 Crossref
|t Bevölkerung Deutschlands bis 2060. 13. koordinierte Bevölkerungsvorausberechnung
|o Statistisches Bundesamt Bevölkerung Deutschlands bis 2060. 13. koordinierte Bevölkerungsvorausberechnung 2013
999 C 5 |9 -- missing cx lookup --
|a 10.1159/000310350
|2 Crossref
|o 10.1159/000310350
999 C 5 |9 -- missing cx lookup --
|a 10.3111/13696998.2015.1014090
|2 Crossref
|o 10.3111/13696998.2015.1014090
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.jval.2011.04.005
|2 Crossref
|o 10.1016/j.jval.2011.04.005
999 C 5 |9 -- missing cx lookup --
|a 10.1186/1472-6963-13-2
|2 Crossref
|o 10.1186/1472-6963-13-2
999 C 5 |9 -- missing cx lookup --
|a 10.5414/CP202729
|2 Crossref
|o 10.5414/CP202729
999 C 5 |9 -- missing cx lookup --
|a 10.1001/jamaneurol.2017.1964
|2 Crossref
|o 10.1001/jamaneurol.2017.1964
999 C 5 |y 2017
|2 Crossref
|t Assessing the socioeconomic Impact of Alzheimer’s Diseases in Western Europe and Canada
|o The Economist Assessing the socioeconomic Impact of Alzheimer’s Diseases in Western Europe and Canada 2017
999 C 5 |y 2016
|2 Crossref
|t GKV-Arzneimittelindex
|o WIdO (Wissenschaftliches Institut der AOK) GKV-Arzneimittelindex 2016
999 C 5 |y 2011
|2 Crossref
|t Einheitlicher Bewertungsmaßstab (EBM), Ausgabe mit Euro-Beträgen auf der Grundlage des bundeseinheitlichen Orientierungspunktwertes
|o Kassenärztliche Vereinigung Einheitlicher Bewertungsmaßstab (EBM), Ausgabe mit Euro-Beträgen auf der Grundlage des bundeseinheitlichen Orientierungspunktwertes 2011


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21